SAN
DIEGO, Dec. 23, 2024 /PRNewswire/ -- Heron
Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a
commercial-stage biotechnology company, announced today the
relocation of the Company's headquarters from San Diego, California to Cary, North Carolina, effective January 1, 2025. A majority of Heron's Management
Team and corporate employees work from the Cary office, which is near the Research Triangle Park ("RTP"), one of the
most prominent high-tech research and development parks in
the United States. The growing
biotech community in Cary and its
surrounding areas provides ample space for growth and
expansion.
"We are excited to move our headquarters to Cary, North Carolina, which represents a
significant milestone in Heron's journey," said Craig Collard, Chief Executive Officer of Heron.
"This move will not only strengthen our ability to support our
employees by centralizing our operations and resources, but also
positions us in an excellent location from which we can continue
making strategic partnerships as we growing our existing portfolio
focused on improving the lives of patients in the acute and
oncology care settings. This is an exciting chapter for Heron, and
we look forward to the continued success and partnerships that lie
ahead."
The new address for Heron's corporate headquarters is 100
Regency Forest Drive, Suite 300, Cary,
NC 27518.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage
biotechnology company focused on improving the lives of patients by
developing and commercializing therapeutic innovations that improve
medical care. Our advanced science, patented technologies, and
innovative approach to drug discovery and development have allowed
us to create and commercialize a portfolio of products that aim to
advance the standard-of-care for acute care and oncology patients.
For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as
defined by the Private Securities Litigation Reform Act of 1995.
Heron cautions readers that forward-looking statements are based on
management's expectations and assumptions as of the date of this
news release and are subject to certain risks and uncertainties
that could cause actual results to differ materially. Therefore,
you should not place undue reliance on forward-looking statements.
Important factors that could cause actual results to differ
materially from those in the forward-looking statements are set
forth in our most recent Annual Report on Form 10-K and any
subsequent Quarterly Reports on Form 10-Q, and in our other reports
filed with the Securities and Exchange Commission, including under
the caption "Risk Factors." Forward-looking statements reflect our
analysis only on their stated date, and Heron takes no obligation
to update or revise these statements except as may be required by
law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400
View original content to download
multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-announces-corporate-headquarters-relocation-to-cary-north-carolina-302338528.html
SOURCE Heron Therapeutics, Inc.